PRESS RELEASE published on 11/06/2024 at 17:40, 1 year 3 months ago VALBIOTIS to launch Valbiotis®PRO Metabolic Health (Totum•63) for the prevention of metabolic diseases on the French market in February-March 2025. Valbiotis announces the launch of Valbiotis®PRO Metabolic Health (Totum•63) on the French market in February-March 2025, addressing metabolic diseases preventively Valbiotis Prevention French Market Metabolic Health TOTUM•63
BRIEF published on 11/05/2024 at 18:05, 1 year 3 months ago Valbiotis approuve le programme de rachat d'actions lors de l'Assemblée Générale Rachat D'actions Assemblée Générale Valbiotis Compléments Alimentaires Résolutions Votées
BRIEF published on 11/05/2024 at 18:05, 1 year 3 months ago Valbiotis approves share buyback program at General Meeting Share Buyback Valbiotis General Assembly Food Supplements Resolutions Voted
PRESS RELEASE published on 11/05/2024 at 18:00, 1 year 3 months ago VALBIOTIS SA: Compte-rendu de l’Assemblée Générale Ordinaire du 5 novembre 2024 Valbiotis SA a tenu son Assemblée Générale Ordinaire le 5 novembre 2024. Les actionnaires votent à l'unanimité pour un programme de rachat d'actions. Valbiotis, spécialisé en nutrition santé, vise la lutte contre les maladies cardiovasculaires Assemblée Générale Valbiotis Maladies Cardiovasculaires Résultats Des Votes Nutrition Santé
BRIEF published on 10/29/2024 at 17:45, 1 year 3 months ago Valbiotis Reports H1 2024 Financial Results and Strategic Developments Valbiotis Product Launch Strategic Roadmap Interim Financials Scientific Results
BRIEF published on 10/29/2024 at 17:45, 1 year 3 months ago Valbiotis publie ses résultats financiers et ses développements stratégiques pour le premier semestre 2024 Valbiotis Lancement De Produit États Financiers Intermédiaires Feuille De Route Stratégique Résultats Scientifiques
PRESS RELEASE published on 10/29/2024 at 17:40, 1 year 3 months ago VALBIOTIS publishes its interim financial statements Valbiotis publishes interim financial statements for H1 2024 showing a cash position of €18.5M and confirming its commercial roadmap. Key events review the successful launch of Valbiotis@PRO Cholesterol Cash Position Valbiotis Product Launch Interim Financial Statements Commercial Roadmap
PRESS RELEASE published on 10/29/2024 at 17:40, 1 year 3 months ago VALBIOTIS publie ses résultats semestriels Valbiotis publie ses résultats semestriels avec une trésorerie de plus de 18,5 M€ et confirme sa feuille de route commerciale. Lancement réussi de Valbiotis@PRO Cholestérol en France et avancées significatives dans les études cliniques des produits TOTUM. Nouveau DAF nommé pour accompagner le pivot stratégique de l'entreprise Résultats Semestriels Valbiotis Trésorerie Études Cliniques Feuille De Route Commerciale
BRIEF published on 10/17/2024 at 17:45, 1 year 3 months ago Valbiotis : Assemblée Générale Ordinaire du 5 novembre 2024 Actionnaires Contrat De Liquidité Assemblée Générale Valbiotis Compléments Alimentaires
BRIEF published on 10/17/2024 at 17:45, 1 year 3 months ago Valbiotis: Ordinary General Meeting of November 5, 2024 Shareholders Liquidity Contract Valbiotis General Assembly Food Supplements
Published on 02/14/2026 at 01:00, 13 hours 24 minutes ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 16 hours 9 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 20 hours 39 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 23 hours 49 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 06:05, 8 hours 19 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 19 hours 4 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 19 hours 22 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 20 hours 4 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 20 hours 16 minutes ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 18:05, 20 hours 19 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 20 hours 19 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 20 hours 34 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 20 hours 34 minutes ago Nombre total d'actions et droits de vote - janvier 2026